Welcome to

ALK FOUNDATION

It is dedicated to the research, professionalization and formal dissemination of the ClO₂ molecule in the form of CDS and its applications, as well as the understanding of life and health from its most essential expressions, its biological, chemical, electrical, and magnetic nature, leading us to an electromolecular medicine approach for the development of technologies that contribute to the well-being of humanity and life on the planet.

About Us

We are a foundation dedicated to the research and development of innovative technologies and solutions for human, animal, plant and environmental well-being. Since our creation, we have worked tirelessly to generate knowledge and technologies that improve the quality of life and promote sustainability.

Our multidisciplinary team of experts collaborates with various institutions and organisations to carry out high-impact projects that benefit society and the planet.

We are also a healthcare organisation that supports health causes and promotes the motto ‘Saving lives together’.

Our Mission

Our mission is to promote research and development of innovative molecules and technologies that promote the integral wellbeing of humans, plants, animals and the environment.

We are committed to generating sustainable solutions that improve the quality of life and preserve natural resources for future generations.

Our Vision

Our vision is to be the world reference in electromolecular medicine technology , leading the way to innovations that improve the health and well-being of all living beings on our planet.

Our Values

Service
It is our core value, with a firm conviction to help humanity, promoting accessible knowledge for the health and well-being of those who need it most.
Innovation
We encourage creativity and the constant search for new solutions through research.
Collaboration
We work as a team and establish alliances with associations and institutions related to our objectives.
Sustainability
We are committed to practices that protect and preserve the environment.
Ethics
We act with integrity and responsibility in all our actions.

Our Objectives

01 >>

That the CDS chlorine dioxide solution be available worldwide and available to all as an authorized therapeutic technology.

02 >>

May this technology be properly understood and mankind be able to avail itself of its benefits.

03 >>

Develop pioneering research and publications in the field of electromolecular medicine .

04 >>

Cooperation and humanitarian aid, promoting service to humanity through initiatives that support health causes, under the slogan"saving lives together".

05 >>

Establish strategic alliances with academic, governmental and private institutions.

Join Us

>>

Major changes and technologies imply transformation of paradigms; CDS is much more than a drug, it is a vital tool.

>>

We share our experience and knowledge with health professionals to help them find the most accurate diagnosis and treatment.

>>

We provide new developments that the conventional pharmaceutical industry is unwilling or unable to offer.

>>

CDS treatments are a healthy alternative. This is true, and the evidence in hundreds of thousands of cases proves it.

History

In light of a deep conviction to share and investigate the causes underlying his own recovery from a chronic degenerative disease (arthritis) through the use of an unknown oxidative molecule, Dr. h. c. Andreas Ludwig Kalcker, embarks on a journey to study and understand the mechanisms that made this recovery possible.

Over the next few years, his research was joined by countless reports of recovery from many different ailments and with them more questions to answer.

In 2012, Dr. Kalcker developed an advanced variant of chlorine dioxide known as CDS, which offers remarkable improvements over traditional two-component mixed solutions by eliminating adverse effects . Simultaneously, he published his first book entitled

 

« CDS, Health is Possible », meticulously based on his thesis and personal experiences. These serve as the basis for his profound knowledge of the field.

Based on his research conducted in Switzerland, he has diligently filed and successfully obtained several patents for therapeutic applications targeting hypoxia, inflammation, infection, sepsis and the SARS-CoV-2 coronavirus. These patents are free worldwide. In 2016 he published a highly acclaimed book entitled « Health forbidden – Incurable was yesterday », in which he presents a list of protocols and another one of A-Z reports, with this book he continues the journey of sharing knowledge around the world taking it to the most needy regions of the African and American continents, not knowing that ending this 2019 tour in the south of America, would come 2020 with the Coronavirus “pandemic”, during this time the efforts multiply and the reach to share this knowledge crosses borders and languages, his extensive publications on the ClO₂ mechanism in SARS-CoV-2 viruses have managed to save hundreds of thousands of lives and great medical attention and acceptance. Achieving also the enactment of a law for the therapeutic use of CDS in Bolivia.

At the end of 2021, Dr. Kalcker made a tour of Mexico, where he was donated a building based in Jalisco, and it is there that the dream of building the first research center in Latin America, specializing in the ClO₂ molecule and the Chlorine Dioxide Solution begins, by 2022 and thanks to donations from the community, begins the constitution, remodeling and equipping of the ALK Foundation, currently the administrative offices, the training room, laboratory and research center are in operation, for the benefit of humanity and the service of our members.

>>>

We

At our organization, we firmly believe that there is always hope for solving seemingly unsolvable problems.

Through our dedication to research and development, we provide a beacon of hope and progress, demonstrating that with creativity, collaboration and commitment, we can overcome any obstacle and create a brighter future for all.
<< A HUMAN TEAM FOR THE SERVICE OF LIFE >>

"SAVING LIVES TOGETHER".